We are excited to inform you that our study abstract on lenalidomide exposed RRMM patients has been accepted for poster presentation at the 64th annual ASH Conference in December 2022! Using...

ITEM CODE: RF-247386 | DATE OF PREPARATION: NOVEMBER 2022

We had our very first HONEUR Board meeting on 23 September 2022! Thank you to our HONEUR Board members for their engagement and input! It is an honour having you on board. Our HONEUR Board consists...

We are delighted to welcome our 20th Data Partner into the HONEUR network: University Hospital Würzburg, Germany! The University Hospital Würzburg is a pioneer in medical care, research and...

HONEUR has launched its minimum viable product, called “Disease Trajectory Analyzer” (DiTrAn). DiTrAn is a disease-agnostic framework for analysis and visualization of clinical event models...

It brings us great pleasure to share that we have signed the contract with three additional sites to project HONEUR. With these three sites added to the network, HONEUR now has 14 data partners! We...